ReShape is More Than Just ‘The Lap-Band company’Bariatric News caught up with Bart Bandy, CEO of ReShape LifeSciences™, to discuss the latest developments at the company including the...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure2 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity2 days ago